Interní Med. 2006; 8(10): 462-465

CEREBRÁLNÍ TOXOPLAsMÓZA U NEMOCNÉHO S CHRONICKOU MYELOIDNÍ LEUKÉMIÍ PO ALOGENNÍ NEPŘÍBUZENSKÉ TRANSPLANTACI KRVETVORNÝCH BUNĚK

Ladislav Slováček1,2, prof. MUDr. Ladislav Jebavý CSc3,4, MUDr. Brigita Slováčková Ph.D5, MUDr. Jan M. Horáček Ph.D3,4, MUDr. Jaroslav Cerman Ph.D3, Pavel Žák6, MUDr. Petr Prášil7
1 Klinika onkologie a radioterapie FN a LF UK Hradec Králové
2 Univerzita obrany, Fakulta vojenského zdravotnictví, katedra válečného vnitřního lékařství, Hradec Králové
3 II. interní klinika, odd. klinické hematologie FN Hradec Králové
4 Katedra válečného vnitřního lékařství VLA J. E. Purkyně, Hradec Králové
5 Psychiatrická klinika LF UK a FN Hradec Králové
6 II. interní klinika - Oddělení klinické hematologie, LF UK a FN Hradec Králové
7 -

Autoři uvádějí kazuistiku cerebrální toxoplasmózy u nemocného s chronickou myeloidní leukémií po alogenní nepříbuzenské transplantaci krvetvorných buněk.

Published: February 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Slováček L, Jebavý L, Slováčková B, Horáček JM, Cerman J, Žák P, Prášil P. CEREBRÁLNÍ TOXOPLAsMÓZA U NEMOCNÉHO S CHRONICKOU MYELOIDNÍ LEUKÉMIÍ PO ALOGENNÍ NEPŘÍBUZENSKÉ TRANSPLANTACI KRVETVORNÝCH BUNĚK. Interní Med. 2006;8(10):462-465.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alappat JP, Mathew CF, Jayakumar K. et al. A case of cerebral toxoplasmosis. Neurol India 2000, 48: 185-187. Go to PubMed...
    2. Beauvais B, Garin JF, Lariviere M, Languillat G. Toxoplasmosis and chronic myeloid leukemia. Nouv Rev Fr Hematol Blood Cells 1976, 16 (2): 169-184. Go to PubMed...
    3. Berkow R. et al. Merck Manual - Kompendium klinické medicíny. X-Egem, Praha 1996, 2030-2032.
    4. Colombo FA, Vidal JE, de Oliveira AC et al. Diagnosis of cerebral toxoplasmosis in AIDS patients in Brazil: importance of molecular and immunological methods using peripheral blood samples. J Clin Microbiol. 2005, 43 (10): 5044-5047. Go to original source... Go to PubMed...
    5. Ferreira RA, Oliveira AB, Ribeiro MF. Et al. Toxoplasma gondii: In vitro and vivo activities of the hydroxynaphthoquinone 2-hydroxy -3-(1´-propen-3-phenyl)-1,4-naphthoquinone alone or combined with sulfadiazine. Exp Parasitol. 2006, 1: ahead of print. Go to original source... Go to PubMed...
    6. Flegr J. Imunoglobuliny - protilátky toxoplasmózy. http://www.eurochem.cz/polavolt/org/abecedne/i/popisy/imunoglobuliny.htm.
    7. Gonzalez MI, Caballero D, Lopez C. et al. Cerebral toxoplasmosis and Guillain-Barre syndrome after allogeneic peripherial stem cell transplantation. Transpl Infect Dis. 2000, 2 (3): 145-149. Go to original source... Go to PubMed...
    8. Hájek R, Krahulcová E, Penka M, Mayer J. Autologní transplantace u chronické myeloidní leukémie. http://www.linkos.cz/vzdelavani/2_00/02.php.
    9. Hoffman Ch. Cerebral toxoplasmosis 2005. http://www.hivmedicine.com/textbook/oi/toxo.htm.
    10. Klamová H. Chronická myeloidní leukémie. http://onkologie.zdn.cz/detail.htm?id=40576.
    11. López MA, Bolotner NC, Ramos MH. Actualizacion: Toxoplasmosis cerebral en pacientes noc sida. Revista de Posgrado de la Via Cátedra de Medicina 2004, 126: 17-19.
    12. Luft BJ, Chua A. Central Nervous System Toxoplasmosis in HIV. Pathogenesis. Diagnosis, and Therapy. Curr Infect Dis Rep 2000, 2: 358-362. Go to original source... Go to PubMed...
    13. Menotti J, Vilela G, Romand S. et al. Comparison of PCR - enzyme - linked immunosorbent assay and real-time PCR assay for diagnostic of an unsusual of cerebral toxoplasmosis in a stem cell transplantant recipient. J Clin Microbiol. 2003, 41 (11): 5313-5316. Go to original source... Go to PubMed...
    14. Nath A, Sinai APOD. Cerebral Toxoplasmosis. Curr Treat Options Neurol. 2003, 5 (1): 3-12. Go to original source... Go to PubMed...
    15. Ribera E, Fernandez-Sola A, Juste C. et al. Comparison of high and low doses of Trimethoprim-Sulfamethaxazole fro primary prevention of toxoplasmic encephalitis in HIV-infected patients. Clin Infect Dis 1999, 29: 1461-1466. Go to original source... Go to PubMed...
    16. Rodgers CA, Harris JR. Ocular toxoplasmosis in HIV infection. Int J STD AIDS 1996, 7: 307-309. Go to original source... Go to PubMed...
    17. Ruf B, Schurmann D, Gergmann F. et al. Efficacy of pyrimethamine/sulfadoxine in the prevention of toxoplasmic encephalitis relapse and pneumocystis carinii pneumonia in HIV-infected patients. Eur J Clin Microbiol Infect Dis 1993, 12: 325-329. Go to original source... Go to PubMed...
    18. Segal L, Moal MC, Doucet L. et al. Toxoplasmosis-associated hemophagocytic syndrome in renal tranplantation. Transpl Int. 2006, 19 (1): 78-80. Go to original source... Go to PubMed...
    19. Sotolongo PC, Carrillo PC, Carrillo CC. Toxoplasmosis cerebral durante la infección por el virus de immunodeficiencia humana. Rev Cubana Med. 2002, 41: 5.
    20. Vidal JE, Hernandez AV, de Oliveira AC. Et al. Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and predictors of treatment response in the HAART era. AIDS Patient Care STDS. 2005, 19 (10): 626-634. Go to original source... Go to PubMed...
    21. Weigel HM, de Vries E, Regez RM et al. Cotrimocazole is effective as primary prophylaxis for toxoplasmic encephalitis in HIV-infected patients: a case control study. Scand J Infect Dis 1997, 29: 499-502. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.